Haematology 2018

Phase II study Adverse event profile

Adverse events (AEs) reported in ≥15% of MCL patients 1

Most AEs were grade 1 or 2. 1 There were low rates of grade 3 and 4 adverse events. 1 • The rate of grade 3 bleeding events was 4.5%, there were no grade 4 or 5 events 1 • The most common infection of grade ≥3 was pneumonia (6%) 1

* Febrile neutropaenia 2.7%

. 1. Wang M et al. N Engl J Med 2013; 369: 507-516.